EJMK Ventures’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Sell
1,939
-9
-0.5% -$1.36K 0.12% 132
2026
Q2
$305K Buy
+1,948
New +$292K 0.14% 127

Other funds holding NVS

EJMK Ventures's NVS Position: Q3 2026 in Review

EJMK Ventures reduced its Novartis (NVS) stake by 0.46% in Q3 2026, selling an estimated $1.36K and leaving 1,939 shares worth $276K. The position accounts for 0.12% of the portfolio, ranked #132.

EJMK Ventures first reported a position in NVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $305K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • EJMK Ventures held 1,939 shares of Novartis worth $276K as of Q3 2026.
  • EJMK Ventures sold 9 Novartis shares in Q3 2026, an estimated $1.36K.
  • Novartis made up 0.12% of EJMK Ventures's portfolio in Q3 2026, its #132 holding.
  • EJMK Ventures first reported a position in Novartis in Q2 2026 and has held it in 2 quarters since.
  • EJMK Ventures's Novartis position peaked at $305K in Q2 2026.
  • 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.